ATE424214T1 - Methode und vektor zur behandlung einer nervenverletzung - Google Patents

Methode und vektor zur behandlung einer nervenverletzung

Info

Publication number
ATE424214T1
ATE424214T1 AT06255906T AT06255906T ATE424214T1 AT E424214 T1 ATE424214 T1 AT E424214T1 AT 06255906 T AT06255906 T AT 06255906T AT 06255906 T AT06255906 T AT 06255906T AT E424214 T1 ATE424214 T1 AT E424214T1
Authority
AT
Austria
Prior art keywords
nerve injury
vector
treating nerve
treating
gene
Prior art date
Application number
AT06255906T
Other languages
English (en)
Inventor
Henrich Cheng
Pei-Teh Chang
Original Assignee
Henrich Cheng
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henrich Cheng filed Critical Henrich Cheng
Application granted granted Critical
Publication of ATE424214T1 publication Critical patent/ATE424214T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT06255906T 2005-12-09 2006-11-17 Methode und vektor zur behandlung einer nervenverletzung ATE424214T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/298,821 US20070134204A1 (en) 2005-12-09 2005-12-09 Method for treating nerve injury and vector construct for the same

Publications (1)

Publication Number Publication Date
ATE424214T1 true ATE424214T1 (de) 2009-03-15

Family

ID=38129395

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06255906T ATE424214T1 (de) 2005-12-09 2006-11-17 Methode und vektor zur behandlung einer nervenverletzung

Country Status (7)

Country Link
US (1) US20070134204A1 (de)
EP (1) EP1825862B1 (de)
JP (1) JP2007161704A (de)
CN (1) CN1977976A (de)
AT (1) ATE424214T1 (de)
DE (1) DE602006005462D1 (de)
TW (1) TWI382848B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI434698B (zh) * 2009-08-14 2014-04-21 Eu Sol Biotech Co Ltd 人類酸性纖維母細胞生長因子之醫藥用途
JP2011121882A (ja) * 2009-12-09 2011-06-23 Eu Sol Biotech Co Ltd ヒト酸性繊維芽細胞増殖因子の改変ペプチド
CN106544326B (zh) * 2016-11-07 2020-06-26 中国科学院武汉病毒研究所 顺行跨多级突触、跨神经元的示踪系统

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868113A (en) * 1986-03-03 1989-09-19 Rorer Biotechnology, Inc. Recombinant DNA vector encoding human endothelial cell growth factor
US5173414A (en) * 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
NZ241021A (en) * 1990-12-18 1993-12-23 Amgen Inc Analogues of acidic fibroblast growth factor and pharmaceutical
DE69334238D1 (de) * 1992-09-25 2008-09-25 Aventis Pharma Sa Adenovirus vektoren für die übertragung fremder gene in zellen des zentralen nervensystems, insbesondere im gehirn
FR2716893B1 (fr) * 1994-03-03 1996-04-12 Rhone Poulenc Rorer Sa Virus recombinants, leur préparation et leur utilisation thérapeutique.
US6551618B2 (en) * 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
FR2717495B1 (fr) * 1994-03-18 1996-04-12 Rhone Poulenc Rorer Sa Virus recombinants, préparation et utilisation en thérapie génique.
US6156303A (en) * 1997-06-11 2000-12-05 University Of Washington Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
US6106826A (en) * 1997-12-17 2000-08-22 Wisconsin Alumni Research Foundation Replication competent, avirulent Herpes simplex virus as a vector for neural and ocular gene therapy
AU763049B2 (en) * 1998-12-28 2003-07-10 Arch Development Corporation Efficient and stable (in vivo) gene transfer to cardiomyocytes using recombinantadeno-associated virus vectors
SE0000285D0 (sv) * 1999-12-07 2000-01-31 Mika Lahtinen Medical implant
JP2005040005A (ja) * 2003-07-22 2005-02-17 Toray Ind Inc 組換えｄｎａ及びその用途
WO2005037211A2 (en) * 2003-10-14 2005-04-28 Neurologix Research, Inc. Methods and compositions for the treatment of neurological disease

Also Published As

Publication number Publication date
TW200733977A (en) 2007-09-16
TWI382848B (zh) 2013-01-21
EP1825862A1 (de) 2007-08-29
US20070134204A1 (en) 2007-06-14
DE602006005462D1 (de) 2009-04-16
CN1977976A (zh) 2007-06-13
JP2007161704A (ja) 2007-06-28
EP1825862B1 (de) 2009-03-04

Similar Documents

Publication Publication Date Title
WO2014043547A8 (en) Method and apparatus for nitrogen removal in wastewater treatment
WO2010017556A8 (en) Method and apparatus for fractional deformation and treatment of cutaneous and subcutaneous tissue
ATE531383T1 (de) Therapeutische verwendung eines wachstumsfaktors, metrnl
TW200519202A (en) Modulation of eIF4E expression
ATE541591T1 (de) Verfahren zur verringerung der viralen und mikrobiellen belastung von pankreatin
WO2005099716A3 (en) Method for analyzing the biological age of a subject
DE602006007093D1 (de) Kombinationstherapie zur Behandlung von Diabetes und dadurch bedingten Leiden sowie zur Behandlung von mittels Erhöhung des GLP-1-Spiegels im Blut verbesserten Leiden
ATE403688T1 (de) Vollaromatischer flüssigkristalliner polyester und verfahren zur herstellung desselben
MX2021014919A (es) Induccion de celulas pluripotentes.
ATE366807T1 (de) Fehlpaarungsendonukleasen und verwendungsverfahren
WO2007130474A3 (en) Method of differentiating stem cells into cells of the endoderm and pancreatic lineage
DE602005018981D1 (de) Verfahren zur Herstellung von L-Cystein, und L-Cystein-produzierender Mikroorganismus
WO2005106090A3 (en) Preform produced by electrospinning, method for producting the same and use of such a preform
WO2009140013A3 (en) Methods of reducing greenhouse emissions from animal manure
ATE535231T1 (de) Verfahren zur herstellung von poly-iclc und seine verwendung
ATE447033T1 (de) Methode zur herstellung von pflanzen, welche eine unterdrückte photorespiration und eine verbesserte co2 fixierung aufweisen
ATE367167T1 (de) Aufbereitung von aldesleukin zur pharmazeutischen verwendung
ATE424214T1 (de) Methode und vektor zur behandlung einer nervenverletzung
DE602005022490D1 (de) Mikroorganismus einer escherichia- oder corynebacterium-spezies mit einem fremdgen für nadp-abhängige glycerinaldehyd-3-phosphat-dehydrogenase und verfahren zur herstellung von l-lysin damit
WO2005014607A3 (en) Antisense modulation of stearoyl-coa desaturase expression
WO2010117992A3 (en) Coupled identification and treatment of cancer
MX2009004962A (es) Metodo para tratar asma, rinitis alergia y trastornos de la piel.
ATE404230T1 (de) Implantat aus titan oder einer titanlegierung und verfahren zu seiner oberflächenbehandlung
WO2005102043A3 (en) Use of nickel to correct growth disorders in plants
DE602006014818D1 (de) Methode zur Produktion von Algen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties